Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3545

Arcturus to prioritize mRNA therapeutics in bid to boost rare disease programs

$
0
0
Arcturus Therapeutics is doubling down on mRNA technology. The biotech said Monday that it's prioritizing its experimental self-amplifying mRNA drugs, with a focus on programs for cystic fibrosis and a rare ...

Viewing all articles
Browse latest Browse all 3545

Trending Articles